Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study
Aleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Haematologica
|
March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia
Daniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
British Journal of Haematology
|
May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia
Ana M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
British Journal of Haematology
|
October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Laura Palomo, Mariam Ibáñez, María Abáigar, et al.
Oncotarget
|
January 16, 2016
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
Felix Royo, Patricia Zuñiga-Garcia, Verónica Torrano, et al.
Blood Advances
|
July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms
Oriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Blood Advances
|
October 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
March 12, 2024
DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study
Aleix Noguera-Castells, Ignacio Campillo-Marcos, Veronica Davalos, et al.
Haematologica
|
March 13, 2025
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia
Daniel Medina-Gil, Laura Palomo, Víctor Navarro, et al.
British Journal of Haematology
|
May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia
Ana M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
British Journal of Haematology
|
October 18, 2019
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
Laura Palomo, Mariam Ibáñez, María Abáigar, et al.
Oncotarget
|
January 16, 2016
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
Felix Royo, Patricia Zuñiga-Garcia, Verónica Torrano, et al.
Blood Advances
|
July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms
Oriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.
Blood Advances
|
October 10, 2024
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, et al.
Blood
|
July 29, 2024
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Page
of 5